Immuron Ltd has released a press release.
IMM-529 IND approved by FDA
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immuron
- Immuron Announces Clinical Trial Update
- Clinical Trial Update
- Immuron launch PROIBS for IBS
- Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.
- Immuron Q1 FY26 YoY growth
Later from Immuron
- Immuron New U.S. Department of Defense Award & Clinical Trial Update
- Uniformed Services University to Release Topline Data
- Immuron Reports Continued Sales Growth
- Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
- Appendix 4D and Half Year Report
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron